Sunitinib for the treatment of gastrointestinal stromal tumours

  • Technology appraisal guidance
  • TA179
  • Published: 
Download guidance (PDF)

Update information

Minor changes since publication

February 2014: Implementation section updated to clarify that sunitinib is recommended as an option for treating gastrointestinal stromal tumours.

ISBN: 978-1-4731-5669-2